Abstract
Lung cancer is the leading cause of cancer-related mortality in Japan, with non-small cell lung cancer (NSCLC) accounting for ∼85%. There is a paucity of research in Japan on clinical characteristics, treatment outcomes and prognostic factors of NSCLC. This real-world study aimed to understand patient characteristics and treatment strategies for NSCLC management in Japan.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
